Newsroom

Sorted by: Latest
-

Resumen: Graanul anuncia un acuerdo con el 50 % de los tenedores de bonos para prorrogar hasta 2029 el vencimiento de los bonos vigentes, por un importe total de 630 millones de euros

LUXEMBURGO--(BUSINESS WIRE)--Cullinan Holdco SCSp (el "emisor" y conjuntamente con sus filiales, "Graanul" o el "grupo") tiene el orgullo de anunciar que ha suscrito un acuerdo de apoyo a la transacción (el "acuerdo de apoyo a la transacción") con los tenedores de los bonos (los "titulares participantes") que representan conjuntamente el 50 % del capital inicial total de sus (i) bonos senior garantizados vinculados a la sostenibilidad al 4,625 % con vencimiento en 2026 (los "bonos a tasa fija v...
-

Riassunto: Graanul annuncia di avere siglato un accordo con il 50% dei titolari delle obbligazioni per estendere la scadenza di attuali obbligazioni per un valore nominale complessivo di 630 milioni di euro fino al 2029

LUSSEMBURGO--(BUSINESS WIRE)--Cullinan Holdco SCSp (l’“Emittente” e, insieme alle sue affiliate, “Graanul” o il “ Gruppo”) annuncia di avere stipulato un accordo di supporto alla transazione (l’“Accordo di supporto alla transazione”) con vari obbligazionisti (i “Partecipanti all’accordo”) che rappresentano collettivamente il 50% del valore nominale complessivo delle sue (i) obbligazioni senior garantite a tasso fisso indicizzate alla sostenibilità con cedola del 4,625% in scadenza nel 2026 (le...
-

Společnost Multiply Group dokončila akvizici společnosti Tendam, zdvojnásobila provozní EBITDA a rozšířila svou globální působnost

ABÚ ZABÍ, Spojené arabské emiráty & MADRID & LONDÝN & LUCEMBURK & PAŘÍŽ--(BUSINESS WIRE)--Multiply Group (ADX: MULTIPLY), investiční holdingová společnost se sídlem v Abú Dhabí, která investuje a provozuje podniky po celém světě, dnes dokončila svou první významnou investici v Evropě akvizicí většinového podílu ve společnosti Tendam, druhé největší oděvní skupině ve Španělsku podle tržního podílu1. Tato transakce zdvojnásobuje provozní EBITDA společnosti Multiply po konsolidaci a rozšiřuje její...
-

Securities Fraud Investigation Into Molina Healthcare, Inc. (MOH) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of Molina Healthcare, Inc. (“Molina” or the “Company”) (NYSE: MOH) on behalf of investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON MOLINA HEALTHCARE, INC. (MOH), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On July 7, 2025, Molina provided preliminary financial results...
-

CORRECTING and REPLACING Zip Marks Fifth Anniversary with New Offices in San Francisco and New York

SAN FRANCISCO--(BUSINESS WIRE)--Zip Marks Fifth Anniversary with New Offices in San Francisco and New York Amid Explosive Growth; Surpasses Billions in Processed Requests...
-

Squamish municipal workers vote 100 percent in favour of strike action

SQUAMISH, British Columbia--(BUSINESS WIRE)--“This 100 percent strike vote demonstrates that our members are deeply concerned about the lack of progress at the bargaining table and the unwillingness of the District of Squamish to address important issues affecting its frontline workers,” says CUPE 2269 President Celeste Bickford. “We’ve continued to see significant increases to the cost of living in our region with people leaving the community because they simply cannot afford to live here anym...
-

Sarepta Therapeutics Provides Clarifying Statement on ELEVIDYS

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today issued the following statement: Just before 6:00 p.m. ET today, the U.S. Food and Drug Administration (FDA) issued a press release announcing an investigation into the death of an eight-year-old Duchenne muscular dystrophy (Duchenne) patient who had received ELEVIDYS (delandistrogene moxeparvovec) gene therapy. The death of this patient was deemed unrela...
-

CARGO THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of CARGO Therapeutics, Inc. - CRGX

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of CARGO Therapeutics, Inc. (NasdaqGS: CRGX) to Concentra Biosciences, LLC. Under the terms of the proposed transaction, Concentra will acquire CARGO for $4.379 in cash per share, plus one non-transferable contingent value right, representing the right to receive: (i) 100% of the closing net cash of CA...
-

TC BANCSHARES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of TC Bancshares, Inc. - TCBC

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of TC Bancshares, Inc. (OTC: TCBC) to Colony Bankcorp, Inc. (NYSE: CBAN). Under the terms of the proposed transaction, shareholders of TC will have the right to elect to receive either $21.25 in cash or 1.25 shares of Colony’s common stock in exchange for each share of TC Bancshares common stock,...
-

Accord annonce une mise à jour de sa facilité bancaire

TORONTO--(BUSINESS WIRE)--Accord Financial Corp. (« Accord » ou la « Société ») (TSX – ACD) annonce aujourd’hui être parvenue à un accord avec son syndicat prêteur visant une prolongation à court terme de sa principale facilité de crédit du 26 juillet 2025 au 8 août 2025. La Société et ses prêteurs sont en discussion relativement à une modification de la facilité de crédit qui devrait prolonger la date d'échéance jusqu'en décembre 2025, et la prolongation donnera plus de temps pour que cette mo...